Support your patients with an effective and non-invasive solution for dysmenorrhoea, PMS, PMDD, and endometriosis without side effects.

Samphire Neuroscience is the first neurotechnology company dedicated exclusively to women’s health. Our medical grade technology addresses the unique and urgent health challenges faced by women. These diagnoses, such as dysmenorrhoea, PMDD, and severe PMS have been long overlooked in research and product development and have a limited range of clinically validated treatment options.

Samphire wants to partner with primary care providers to deliver evidence-based solutions that are safe, effective, and tailored specifically to women’s needs without side effects. Our first product, Nettle, a CE-marked (Class IIa) medical device, is an at home, wearable headband for treating low mood and pain symptoms associated with menstruation.

With outstanding clinical efficacy and a significantly lower price point - Nettle is available for £449, compared to the £8,000 cost of 30 sessions of TMS - our technology offers an accessible and effective alternative for patients seeking relief.

Nettle integrates easily into daily life, creating striking improvement and relief. We intend to empower both clinicians and their female patients with cutting-edge health solutions that advance the equity and innovation in women’s healthcare.